Carmel arts center makes room for more sponsors
The Center for the Performing Arts in Carmel expects the 2012-13 concert season, announced this week, to bring a healthy bump in sponsor revenue.
Home » Search
Search Results
4,592 results for 'mental health'
- Sort By
-
Date
- Any Time
- Past Day
- Past Week
- Past Month
- Past Year
-
Custom Date Range
Articles
New Lilly drug has small sales potential
Eli Lilly and Co.’s newest drug is a boon for Alzheimer’s research but is likely to bring the Indianapolis drugmaker less than $100 million in annual sales—at least initially, according to one of the few analysts to make a forecast.
Lugar, Mourdock prepare for lone debate in Senate race
Until now, Indiana's Senate Republican primary race between longtime U.S. Sen. Richard Lugar and Indiana Treasurer Richard Mourdock has been dominated by television ads, millions of campaign phone calls and foment among Indiana's strong base of conservative voters:
KENNEDY: Republicans losing the 51 percent
In a recent New York Times column, Gail Collins observed “the thing that makes our current politics particularly awful isn’t procedural. It’s that the Republican Party has become over-the-top extreme.” She left out “mean-spirited and patriarchal.”
Young Indy-area tech entrepreneurs enjoy deep support
MyJibe co-founder Mike Langellier is among a new generation of tech entrepreneurs in the Indianapolis area that benefits from a host of support their predecessors never enjoyed.
Supreme skepticism boosts WellPoint stock
Wall Street's favorable reaction came not only because harsh questioning by the U.S. Supreme Court’s conservative justices put in doubt the health reform law’s mandate that all Americans buy health insurance, but also because the justices raised the possibility that they would strike down requirements that insurers accept all customers, regardless of health.
MEREDITH: Respect, reverence has devolved to blame, distrust, sadness
The Indiana’s Department of Education appears to have an attitude that teaching is just a stopover on the way to something better.
BROOKS: Will Obama go All In on big domestic issues?
It will be interesting, over the course of this campaign, to see what’s underneath the cageyness.
FRIEDMAN: Big debate over future prosperity goes missing
What is American capitalism today, and what will enable it to thrive in the 21st century?
WILLIAMS: It really is the right to work for less
In which category do the 23 right-to-work states lead the nation? In poverty.
Company news
Indianapolis-based Prosolia Inc. has licensed technology from the estate of John B. Fenn, a chemistry professor who won the 2002 Nobel Prize for developing new mass spectrometry. Prosolia makes instruments that can identify chemicals on paper, skin, fluids and other surfaces. The eight-person firm hopes the technology allows it to launch new products next year to broaden its portfolio. Prosolia CEO Justin Wiseman said the Fenn technology “opens up less-penetrated markets in environmental, security, medical and food chemistry. We foresee several new product innovations from the Fenn technology, which we plan to commercialize in the near future."
Carmel-based CNO Financial Group Inc. has agreed to repay five customers more than $1 million that a former independent insurance agent stole from them, according to a report by A.M. Best Co. Jasmine Jamrus-Kassim sold annuities for Chicago-based Bankers Life and Casualty Co., a subsidiary of CNO Financial. She was arrested in March 2011 after an investigation by Washington state insurance regulators and has now been sentenced to six years in prison. The victims, age 74 to 90, thought the money was being reinvested but Kassim instead spent it to pay for online psychics, clothes, jewelry and a trip to Mexico, according to records from the Washington investigation.
Endocyte Inc. will submit its ovarian cancer drug EC145 for European market approval in the third quarter after the European Commission granted it "orphan drug" status. The submission means West Lafayette-based Endocyte could have its first commercial product as early as 2013. European regulators granted EC145 orphan status because large numbers of women have ovarian cancers that do not respond to typical chemotherapy treatments. And no new drug has been approved to treat ovarian cancer in 10 years. The European Commission also granted orphan status to an imaging agent Endocyte has developed, called EC20, which lights up ovarian tumors in women that have a genetic variation that makes them bond hungrily to folate. That’s important because EC145 is a combination of a powerful chemotherapy agent and folate, so that it enters cancerous cells but does not enter healthy cells. That allows EC145 to be more deadly to cancer, without serious side effects, than patients can tolerate with traditional chemotherapy agents.
A four-physician OB/GYN practice has merged with Indiana University Health Ball Memorial after a long-standing partnership. The Voss Center for Women of Muncie joined the IU Health system March 1. In addition to its four doctors, the practice includes four nurse practitioners. Hospitals are increasingly employing physicians, as financial pressures increase on independent practices and as reimbursement from public and private health plans encourages doctors and hospitals to work more closely to improve patient health.
How key bills fared during 2012 Indiana legislative session
Right-to-work, smoking ban were only two of a long list of actions taken.
COLVIN: Get ready for a perfect storm in Worker’s Compensation
Rates are set to rise as insurers increasingly note the link between older workers’ health and productivity.
COLVIN: Get ready for a perfect storm in Worker’s Compensation
Rates are set to rise as insurers increasingly note the link between older workers’ health and productivity.
Hospitals push preemptive care with special programs
Hospitals around Indianapolis and the nation are expanding programs to help people before they become patients. They are trying to teach cooking as well as treat cancer, to do social work as well as do surgery.
Company news
Endocyte Inc. can start enrolling patients again in a clinical trial of its experimental cancer drug, the company announced Monday, clearing away a hurdle to getting the drug approved in Europe. The change comes after the U.S. Food and Drug Administration OK’d the importation of the cancer drug Doxil from Europe. Supplies of the drug, made by New Jersey-based Johnson & Johnson, have been short since last fall due to equipment failures at one of Johnson’s suppliers. Endocyte’s Phase 3 clinical trial aims to show that its drug, EC145, when given in combination with Doxil, is a better therapy for certain ovarian cancer patients than Doxil alone. But the West Lafayette-based drug company was forced to halt new patient enrollment last fall because of the worldwide shortage of Doxil. Endocyte had been planning to submit EC145 for market approval in Europe based on its Phase 2 clinical trial results, rather than the more customary wait for results of the lengthy Phase 3 it is now conducting. But the European regulators wanted Endocyte to at least be enrolling patients in a Phase 3 trial—so they could later re-evaluate whether the drug should remain on the market. The Doxil shortage had until now prevented the company from meeting that requirement.
Indianapolis-based Home Health Depot Inc., a home medical equipment company, said on Monday that it plans an expansion that will create up to 80 jobs in the state by 2016. The company said it will invest $1.4 million to expand its headquarters on the north side of Indianapolis and its customer-fulfillment operations across the state. Home Health Depot, which currently has 99 full-time Indiana employees, plans to begin hiring new logistics, administrative, finance and information technology workers this month. The 14-year-old company has eight Indiana facilities in addition to facilities in six other Midwest locations. The company has been on a growth tear, with revenue from 2009 to 2010 doubling to more than $13 million. IBJ in June ranked Home Health Depot fifth on its list of fastest-growing Indianapolis-area private companies. The Indiana Economic Development Corp. offered Home Health Depot up to $700,000 in tax credits and up to $60,000 in training grants based on the company's job-creation plans.
Indianapolis-based HealthNet opened its Barrington Health & Dental Center in February on the east side of Indianapolis. The health center outgrew its former location nearly five years ago. HealthNet, which operates a series of federally qualified community health centers, built the 26,000-square-foot facility adjacent to the old one at 3401 E. Raymond St., quadrupling the health center’s former size and capacity. The expanded center has 43 exam rooms, along with lab and imaging services. The center will offer primary, pediatric, OB-GYN, podiatry, optometry, social work and behavioral health services, as well as access to discounted medicines and nutrition counseling.
CARTER: Community enthusiasm palpable with eco causes
Indianapolis is beginning to focus on environment, livability.